tirzepatide red at injection site Tirzepatide-Induced Reaction Injection Site Reactions with Tirzepatide:

These results position Tirzepatide as a highly effective and advantageous alternative to insulin intensification, offering superior glycemic control while simultaneously addressing the common comorbidity of obesity, a benefit not provided by insulin therapy

Most patients notice changes within 2-3 months of starting treatment, often coinciding with the first 5-10% weight loss

Moreover, the combination of these receptor agonists can lead to enhanced glycemic control and a greater impact on body weight, making Tirzepatide a versatile tool in the management of obesity and type 2 diabetes

Data availability The full set of de-identified summary statistics can be made available to qualified investigators who enter into an agreement with 23andMe that protects participant confidentiality